HGH Therapy

In 1990 Dr. Rudman proved in clinical tests, as reported in the New England Journal of Medicine (Vol. 323:1-6, July 5, 1990, Number 1), that injections of somatotropin ( HGH ) had a significant impact on lean muscle growth and reduction of adipose tissue in men over 60 years old as well as thickening of the skin and bone density. His conclusions ignited a revolution in anti aging therapy : "Diminished secretion of human growth hormone is responsible in part for the decrease of lean body mass, the expansion of adipose-tissue mass, and the thinning of the skin that occur in old age."

Clinical results of HGH therapy consistently indicate increased muscle mass, reduction in body fat, enhanced immune function, improved healing rate, hair regrowth and coloration, thickening of the skin, improved mental function, increased endurance and improved sexual function.

Somatotropin ( HGH ) goes far beyond other endocrine hormones, such as testosterone, estrogen, progesterone and DHEA, to not only inhibit biological aging, but to significantly reverse many of the effects of aging. The side effects and high cost of HGH injections ( i hGH ), coupled with the knowledge that HGH continues to be produced well into the age of 80, but not released by the pituitary, has led to an abundance of research on HGH secretagogues.

Several research foundations focusing on HGH secretagogues, such as Human Growth Hormone Research Laboratories , involves a class of compounds that directly stimulate the pituitary to release stored HGH and by affecting hypothalamic inhibitors.